Ann-Lise works toward improving access to medicines, health products, and quality care in low-and middle-income countries, with a current focus on NCDs/oncology and rare diseases. She is also playing a leading role on policies at the nexus of climate change and health.

She supports advocacy and policy development on these topics as well as strategic engagement with key international stakeholders, including WHO, international organizations, private sector companies, and civil society organizations.

Prior to joining IFPMA, Ann-Lise worked with the Public Affairs team of Sanofi Global Health, where she promoted the value of Sanofi Global Health’s portfolio in relation to NCDs, tuberculosis, malaria, and anti-microbial resistance.

Ann-Lise is a hospital pharmacist by training who subsequently had a broad range of professional experiences in market access, medical affairs, and health economics at MSD France and the French Health Technology Assessment Agency (Haute Autorité de Santé), and clinical experiences in the University Hospitals of Bordeaux and Toulouse in France.

Ann-Lise has a PharmD degree with a specialization in Hospital Pharmacy from the University Paul Sabatier of Toulouse), with complementary diplomas in health economics from the School of Public Health of Bordeaux, statistics for medical trials from Pierre and Marie Curie University of Paris, and climate change and economic governance from the London School of Economics.